Statistics
Publications
20
Citations
2.8K
H-Index
18
Active since
1994
Mark R. Albertella is an author at University of Cambridge specializing in molecular oncology, pharmacology, and oncology.
Publications per year
1994–2024
20
20
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova, Wesley Blackaby, Mark R. Albertella et al. · Nature · 2021 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +13
A Role for Polymerase η in the Cellular Tolerance to Cisplatin-Induced Damage
Mark R. Albertella, Catherine Green, Alan R. Lehmann et al. · Cancer Research · 2005 · 204 citations
Aneuploid colon cancer cells have a robust spindle checkpoint
Anthony Tighe, Victoria Johnson, Mark R. Albertella et al. · EMBO Reports · 2001 · 172 citations · Full text
1–5 of 20